Nevia bio

Company Overview

Snapshot

Founded in January 2020 by Inbal Zafir-Lavie, Shlomit Yehudai-Resheff, and Roni Michaely, Nevia bio operates with 11–50 employees. The company has raised $5 million across three funding rounds from four investors. In August 2023, Nevia bio completed a Seed round, with MindUP participating.

Business overview

Nevia bio is a health technology company focused on transforming women's health through non-invasive, AI-driven diagnostic solutions. The company specializes in the discovery of biomarkers in vaginal fluid for the early detection of gynecological cancers, initially concentrating on ovarian cancer. By leveraging a large database of vaginal fluid and multi-omics data, Nevia bio aims to detect cancers at their earliest stages, serving the Health Tech & Life Sciences sector with its innovative diagnostic platform.

Strategic signal

In July 2023, Nevia Bio was highlighted for its use of AI in the early detection of ovarian cancer, often referred to as a "silent killer." This signals the company's progress in leveraging advanced technology to address critical unmet needs in women's health, demonstrating potential for significant impact on patient outcomes and the diagnostic market.

Company Intelligence Q&A

When was Nevia bio founded?

Nevia bio was founded in January 2020.

Who are the founders of Nevia bio?

The founders of Nevia bio are Inbal Zafir-Lavie, Shlomit Yehudai-Resheff, and Roni Michaely.

What was the most recent funding event for Nevia bio?

In August 2023, Nevia bio completed a Seed round led by MindUP to build a machine learning-enabled platform for the early detection of women-related diseases.

What is Nevia bio's primary focus in diagnostics?

Nevia bio focuses on developing non-invasive, AI-driven diagnostic solutions for the early detection of gynecological cancers, with an initial emphasis on ovarian cancer, by discovering biomarkers in vaginal fluid.

Which investors participated in Nevia bio's August 2023 Seed round?

The August 2023 Seed round for Nevia bio included investment from MindUP and ALIVE Israel Healthtech Fund.